PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
17-Aug-2021 Alzamend Neuro Announces It Has Contracted With Altasciences to Conduct a Phase I Relative Bioavailability Study for AL001 for Dementia Related to Alzheimer’s Disease in September 2021 Businesswire
17-Aug-2021 Tenax Therapeutics Reports Second Quarter 2021 Results and Provides Business Update Businesswire
17-Aug-2021 Sparrow Pharmaceuticals Expands Executive Leadership With Appointment of Frank Czerwiec, MD as Chief Medical Officer and Jamie MacPherson, PharmD as Vice President of Regulatory Affairs and Quality Businesswire
17-Aug-2021 CURE Pharmaceutical Reports Second Quarter 2021 Revenue Rose Nearly 700% Driven by Sales from Sera Labs Product Lines Businesswire
17-Aug-2021 Akili Enters Strategic Licensing Agreement with TALi, Extending Akili Portfolio and Industry Leadership in Prescription Digital Therapeutics for Cognitive Impairments Businesswire
17-Aug-2021 Xellia Pharmaceuticals Cleveland, Ohio Manufacturing Facility Commercially Operational for Production of Key Anti-Infective Drug Products for US Hospitals and Patients Businesswire
17-Aug-2021 Receptor Life Sciences Announces Publication of Proof-of-Principle Clinical Pharmacokinetics Study of RLS103 (Inhaled Dry Powder CBD) Businesswire
17-Aug-2021 Global $46.33 Bn Plant Extracts Markets to 2028 - Focus on Phytomedicines & Herbal Extracts, Essential Oils, Spices, Flavors & Fragrances - ResearchAndMarkets.com Businesswire
17-Aug-2021 The IMA Group Announces Acquisition of MedPlus Disability Evaluations Businesswire
17-Aug-2021 $300+ Bn Contract Development and Manufacturing Organization (CDMO) Markets - Global Analysis & Forecast Report 2021-2026 - ResearchAndMarkets.com Businesswire
17-Aug-2021 Papyrus Therapeutics Inc. Announces Additions to Its Board of Directors Businesswire
17-Aug-2021 Antibe Therapeutics Reports Q1 2022 Interim Financial and Operating Results Businesswire
17-Aug-2021 VerkaziaTM (cyclosporine 0.1%) for the Treatment of Severe Vernal Keratoconjunctivitis is Now Reimbursed by Non-Insured Health Benefits (NIHB) Program Businesswire
17-Aug-2021 BeiGene and EUSA Pharma Announce China NMPA Approval of QARZIBA® (Dinutuximab Beta) for Patients with High-Risk Neuroblastoma Businesswire
17-Aug-2021 Carbon Health Debuts at #2 on the Inc. 5000 2021 List Businesswire
17-Aug-2021 Cybin Files 14th Patent Application Further Strengthening its IP Portfolio and Receives a Favorable Patent Claim Opinion Businesswire
17-Aug-2021 VerkaziaMC (cyclosporine à 0,1 %) est désormais remboursé par le Programme des services de santé non assurés (SSNA) pour traiter la kératoconjonctivite vernale grave Businesswire
17-Aug-2021 EMA Validates Bristol Myers Squibb’s Applications for Opdivo (nivolumab) + Yervoy (ipilimumab) and Opdivo + Chemotherapy as First-Line Treatments for Unresectable Advanced, Recurrent or Metastatic Esophageal Squamous Cell Carcinoma Businesswire
17-Aug-2021 Brazil High-Level Disinfectants & Terminal Sterilization Services Markets, 2021-2028 - Increasing Prevalence of Hospital Acquired Infections (HAIs) and Surge in COVID-19 Cases - ResearchAndMarkets.com Businesswire
17-Aug-2021 Global Giant Cell Arteritis Treatment Market Analysis and Forecast Report 2021-2026: Major Players are F. Hoffmann-La Roche, Kiniksa Pharma, Teva Pharma, & Tianjin Tianyao Pharma - ResearchAndMarkets.com Businesswire